Skip to main content
Premium Trial:

Request an Annual Quote

TranSmart Informatics Platform to be Used in $1M Phelan-McDermid Syndrome Research Project

NEW YORK (GenomeWeb) – The TranSmart Foundation said today that its data-sharing and -analysis platform will be used by the Phelan-McDermid Syndrome Foundation and the Center of Biomedical Informatics at Harvard Medical School as part of a nearly $1 million contract research project.

The contract, from the Patient-Centered Outcomes Research Institute (PCORI), will support the team's efforts to collect and integrate previously gathered medial and research data "to advance knowledge and expedite research inquiries for families affected with Phelan-McDermid Syndrome," a genetic condition that can severely impact brain development and which has been associated with autism spectrum disorders, TranSmart said.

The Phelan-McDermid Syndrome Foundation and Paul Avillach at the Center for Biomedical Informatics at Harvard previously formed the Phelan-McDermid Syndrome Data Network (PMSDN), a project that with 28 others form PCORnet, a national network established by PCORI to conduct clinical outcomes research .

With the new contract, PMSDN will use TranSmart's open source knowledge management platform, cTAKES, a natural language processing tool, and the i2b2 (informatics for integrating biology and the bedside) data model to provide an informatics backbone for researchers to mine diverse datasets and share insights with the PCORnet research partners, TranSmart said.

"Using the functionality of i2b2 features in TranSmart, we are able to integrate patient and family-reported outcomes from the Phelan-McDermid Syndrome International Registry and electronic health records to help us effectively mine data and better understand" the syndrome, Avillach, the co-principal investigator at the PMSDN project at Harvard, said in a statement.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.